Title : mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells.

Pub. Date : 2021 Apr

PMID : 33073679






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells. Cisplatin mechanistic target of rapamycin kinase Homo sapiens
2 The purpose of this study was to investigate the effect of therapeutic inhibition of mTOR (mechanistic target of rapamycin) on resistance of CSCs to cisplatin, a prototypic platinum-based chemotherapeutic agent. Cisplatin mechanistic target of rapamycin kinase Homo sapiens
3 The purpose of this study was to investigate the effect of therapeutic inhibition of mTOR (mechanistic target of rapamycin) on resistance of CSCs to cisplatin, a prototypic platinum-based chemotherapeutic agent. Cisplatin mechanistic target of rapamycin kinase Homo sapiens
4 We observed that cisplatin induced mTOR and S6K1 phosphorylation, increased the number and size of MEC salispheres, and induced Bmi-1 expression and the fraction of CSCs in MEC models in vitro. Cisplatin mechanistic target of rapamycin kinase Homo sapiens
5 In contrast, mTOR inhibition (e.g., temsirolimus) blocked cisplatin-induced Bmi-1 expression and salisphere formation in vitro. Cisplatin mechanistic target of rapamycin kinase Homo sapiens